Literature DB >> 10229073

Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals.

P André1, C Brunet, S Guia, H Gallais, J Sampol, E Vivier, F Dignat-George.   

Abstract

NK and T lymphocytes share various cell surface receptors, including NK receptors for MHC class I molecules (NKR). NKR include killer cell Ig-like receptors (KIR) and lectin-like dimers which are composed of the invariant CD94 associated with a variety of NKG2 molecules. The combination of KIR and CD94/NKG2 dimers expressed on NK and T cell subsets defines a repertoire of MHC class I recognition. Engagement of NKR by cognate MHC class I molecules governs T and NK cell activation. We investigated the NKR distribution on NK and T cell subsets from uninfected and HIV-infected individuals, according to the clinical status, the absolute numbers of CD4+ T cells as well as the plasmatic viral load of the patients. We show that the KIR distribution on NK cells is not affected by HIV-1 infection, whereas the absolute numbers of T cells expressing specific KIR members (CD158b, p70) transiently increase in early stages of HIV infection. By contrast, the percentages of NK and T cells which express CD94 dimers increase in parallel with the disease. These results document a differential regulation of KIR and CD94 lectin-like dimers during the course of a chronic viral infection in humans and further suggest that both types of NKR are independently regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229073     DOI: 10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Dendritic cells and natural killer cells in the pathogenesis of HIV infection.

Authors:  Claudio Fortis; Guido Poli
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.

Authors:  M Nedim Ince; Brooke Harnisch; Zhan Xu; Sang-Kyung Lee; Christoph Lange; Lorenzo Moretta; Michael Lederman; Judy Lieberman
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

4.  Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Hendrik Streeck; Nickolas Teigen; Alicja Piechocka-Trocha; Kristin Moss; Kristen Cohen; Angela Meier; Florencia Pereyra; Bruce Walker; Marcus Altfeld
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

6.  Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.

Authors:  Jakob Michaëlsson; Brian R Long; Christopher P Loo; Lewis L Lanier; Gerald Spotts; Frederick M Hecht; Douglas F Nixon
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

7.  Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection.

Authors:  Edmond J Yunis; Viviana Romero; Felipe Diaz-Giffero; Joaquin Zuñiga; Prasad Koka
Journal:  J Stem Cells       Date:  2007

8.  In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infection.

Authors:  Rita D Simões; Kristina E Howard; Gregg A Dean
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 9.  Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Authors:  Pascale André; Caroline Denis; Caroline Soulas; Clarisse Bourbon-Caillet; Julie Lopez; Thomas Arnoux; Mathieu Bléry; Cécile Bonnafous; Laurent Gauthier; Ariane Morel; Benjamin Rossi; Romain Remark; Violette Breso; Elodie Bonnet; Guillaume Habif; Sophie Guia; Ana Ines Lalanne; Caroline Hoffmann; Olivier Lantz; Jérôme Fayette; Agnès Boyer-Chammard; Robert Zerbib; Pierre Dodion; Hormas Ghadially; Maria Jure-Kunkel; Yannis Morel; Ronald Herbst; Emilie Narni-Mancinelli; Roger B Cohen; Eric Vivier
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

10.  Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males: A cross-sectional study.

Authors:  Maike Sperk; Wang Zhang; Piotr Nowak; Ujjwal Neogi
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.